GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the FLOW rule is doing its job and people should stop complaining — 11 comments in the full submission. View in context.
94
c/trialwatch·submitted 4 months ago by u/first_hundred

[Meta] the FLOW rule is doing its job and people should stop complaining

Readoutbranch of 7 comments

STEP. That is the whole post, but I will justify it. Everything else people worry about in c/orforglipron is downstream of it. Titration speed, muscle cramps, the endless dose arguments — most of it resolves if you sort STEP out first, and almost nobody does. I say this having got it wrong for 16 months. My…

Read the full submission and all 11 comments →

This branch

7 comments, started 4 months ago
u/hsa_math13 points·4 months ago

Crossposting this to c/compounding because the people who need it are not reading this community.

replysharereportpermalink
u/trialwatch_theoMOD7 points·4 months ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/first_hundredOP4 points·4 months ago

Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.

replysharereportpermalink
u/rohan_cardoso4 points·4 months ago

Flair changed to match the content.

Disagree on that part. 99.0% and 98.9% on the same vial is normal.

replysharereportpermalink
u/first_hundredOP2 points·4 months ago

Slight fix: the number was 97.6, not 98.9. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/injection_site_iris5 points·4 months ago

Crossposting this to c/compounding because the people who need it are not reading this community.

Disagree on that part. 98.7% and 98.3% on the same vial is normal.

replysharereportpermalink
u/iman_castellanos4 points·4 months ago

Crossposting this to c/compounding because the people who need it are not reading this community.

Disagree on that part. 98.1% and 97.6% on the same vial is normal.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →